US2015320087A1PendingUtilityA1
Trace Element Solution
Est. expiryMay 14, 2032(~5.8 yrs left)· nominal 20-yr term from priority
Inventors:William Alfred Smith
A61K 33/30A61K 31/714A61K 33/34A23K 50/10A61K 33/32A23K 20/30A61K 47/24A61K 33/04A61K 9/0019A61K 33/18A23K 1/1813A23K 1/1603A23K 1/1753A61K 33/24A23K 1/175A23K 20/174
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The inventions discloses a trace element solution, which comprises at least the following metals: zinc; manganese; selenium; and copper; and which comprises Vitamin B12. The solution furthermore comprises butaphosphan to stabilize the Vitamin B12 and the inclusion of butaphosphan may have synergistic activity with the minerals.
Claims
exact text as granted — not AI-modified1 . A trace element solution, which comprises at least the following metals:
(a) zinc; (b) manganese; (c) selenium; and (d) copper;
and which comprises Vitamin B12.
2 . A solution as claimed in claim 1 , in which:
(a) the ratio of zinc to manganese is at least 2:1; (b) the ratio of zinc to manganese is at least 4:1; (c) the ratio of zinc to copper is at least 2:1 or 4:1; and/or (d) the ratio of zinc to selenium is at least 4:1 or 12:1.
3 . A solution as claimed in claim 1 , which comprises the following concentrations:
(a) at least 24 mg/ml zinc; (b) at least 4 mg/ml manganese; (c) at least 2 mg/ml selenium; (d) at least 6 mg/ml copper; and (e) at least 0.6 mg/ml Vitamin B12.
4 . A solution as claimed in claim 1 , in which the concentration of the metals is at least 36 mg/ml.
5 . A solution as claimed in claim 1 , which comprises the following concentrations:
(a) at least 60 mg/ml zinc; (b) at least 10 mg/ml manganese; (c) at least 5 mg/ml selenium; (d) at least 15 mg/ml copper; and (e) at least 1.5 mg/ml Vitamin B12.
6 . A solution as claimed in claim 1 , in which the concentration of the metals is at least 90 mg/ml.
7 . A solution as claimed in claim 1 , which comprises chromium and/or iodine.
8 . A solution as claimed in claim 1 , which comprises butaphosphan to stabilize the Vitamin B12.
9 . A solution as claimed in claim 5 , in which the inclusion of butaphosphan enables the Vitamin B12 to remain more stable.
10 . A solution as claimed in claim 1 , which is an injectable trace element solution.
11 . A solution as claimed in claim 1 , which is visually stable.
12 - 13 . (canceled)
14 . A method of providing trace elements to animals comprising administering the solution of claim 1 .
15 . A solution as claimed in claim 2 , which comprises the following concentrations:
(a) at least 24 mg/ml zinc; (b) at least 4 mg/ml manganese; (c) at least 2 mg/ml selenium; (d) at least 6 mg/ml copper; and (e) at least 0.6 mg/ml Vitamin B12.
16 . A solution as claimed in claim 2 , in which the concentration of the metals is at least 36 mg/ml.
17 . A solution as claimed in claim 2 , in which the concentration of the metals is at least 90 mg/ml
18 . A solution as claimed in claim 2 , which comprises butaphosphan to stabilize the Vitamin B12
19 . A method of providing trace elements to animals comprising administering the solution of claim 2 .
20 . A method of providing trace elements to animals comprising administering the solution of claim 5 .
21 . A method of providing trace elements to animals comprising administering the solution of claim 6 .
22 . A method of providing trace elements to animals comprising administering the solution of claim 9 .Join the waitlist — get patent alerts
Track US2015320087A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.